Cost analysis for CPT 0037U — Dna gene analysis of 324 genes in solid organ tumor tissue
Average Medicare Payment
$3421.48
2023 data
Total Payments (2023)
$53.2M
Services (2023)
15.6K
Price Change (2018–2023)
+3.2%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2018 | $3316.04 | $32.8M | 9.9K | — |
| 2019 | $3418.82 | $78.5M | 23.0K | +3.1% |
| 2020 | $3477.18 | $76.8M | 22.1K | +1.7% |
| 2021 | $3493.01 | $74.1M | 21.2K | +0.5% |
| 2022 | $3449.05 | $61.1M | 17.7K | -1.3% |
| 2023 | $3421.48 | $53.2M | 15.6K | -0.8% |
The most expensive state pays 1.0x more than the cheapest for this procedure. MA averages $3421.48 vs MA at $3421.48.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| MA | $3421.48 | $53.2M | 15.6K | 1 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Foundation Medicine, Inc. | Clinical Laboratory | MA | $53.2M | 15.6K | $3421.48 |
Based on the data, CPT 0037U shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Costs have increased 3.2% since 2018. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.